{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:51:38Z","timestamp":1776408698935,"version":"3.51.2"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-06886-5","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:32:26Z","timestamp":1774312346000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of hematopoietic stem cell transplantation in adult sickle cell disease patients: A Single-Center experience from India"],"prefix":"10.1007","volume":"105","author":[{"given":"Anusha","family":"Swaminathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhil M","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shrinidhi","family":"Nathany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha Rastogi","family":"Panda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aastha","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swati","family":"Bhayana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohini","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Danewa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhur","family":"Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunisha","family":"Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surbhi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherook","family":"J","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachit Dilip","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paritosh","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aakriti","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharti","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanika","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Dua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Bhargava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"issue":"1","key":"6886_CR1","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1182\/hematology.2023000486","volume":"2023","author":"AA Kassim","year":"2023","unstructured":"Kassim AA, DeBaun MR (2023) The range of haploidentical transplant protocols in sickle cell disease: all haplos are not created equally. Hematology 2023(1):532\u2013541","journal-title":"Hematology"},{"issue":"13","key":"6886_CR2","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1182\/bloodadvances.2022009202","volume":"7","author":"B Jiao","year":"2023","unstructured":"Jiao B, Johnson KM, Ramsey SD, Bender MA, Devine B, Basu A (2023) Long-term survival with sickle cell disease: a nationwide cohort study of medicare and medicaid beneficiaries. Blood Adv 7(13):3276\u20133283","journal-title":"Blood Adv"},{"key":"6886_CR3","unstructured":"Km ASM, A H SL, V J, E H, J S, Long-term Survival after Hematopoietic Cell Transplant for Sickle Cell Disease Compared to the United States Population. Transplant Cell Ther [Internet]. 2022 Jun [cited 2025 Feb 13];28(6). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35302009"},{"key":"6886_CR4","unstructured":"Ashorobi D, Naha K, Bhatt R Hematopoietic Stem Cell Transplantation in Sickle Cell Disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Feb 13]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538515\/"},{"issue":"11","key":"6886_CR5","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.3324\/haematol.2017.169581","volume":"102","author":"SD Arnold","year":"2017","unstructured":"Arnold SD, Brazauskas R, He N, Li Y, Aplenc R, Jin Z et al (2017) Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases. Haematologica 102(11):1823\u20131832","journal-title":"Haematologica"},{"issue":"11","key":"6886_CR6","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1182\/blood-2016-10-745711","volume":"129","author":"E Gluckman","year":"2017","unstructured":"Gluckman E, Cappelli B, Bernaudin F, Labopin M, Volt F, Carreras J et al (2017) Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. Blood 129(11):1548\u20131556","journal-title":"Blood"},{"issue":"12","key":"6886_CR7","doi-asserted-by":"publisher","first-page":"e543","DOI":"10.3324\/haematol.2019.216788","volume":"104","author":"B Cappelli","year":"2019","unstructured":"Cappelli B, Volt F, Tozatto-Maio K, Scigliuolo GM, Ferster A, Dupont S et al (2019) Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease. Haematologica 104(12):e543\u2013e546","journal-title":"Haematologica"},{"issue":"4","key":"6886_CR8","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/ajh.26063","volume":"96","author":"I Osunkwo","year":"2021","unstructured":"Osunkwo I, Andemariam B, Minniti CP, Inusa BPD, El Rassi F, Francis-Gibson B et al (2021) Impact of sickle cell disease on patients\u02bc\u2019 daily lives, symptoms reported, and disease management strategies: results from the international sickle cell world assessment survey (SWAY). Am J Hematol 96(4):404\u2013417","journal-title":"Am J Hematol"},{"key":"6886_CR9","doi-asserted-by":"publisher","unstructured":"Aljaafri BA, Albawardi MF, Alghamdi AY, Altowairgi KM, Alhoshan YS, Alahmari B, Alsadi H, Ahmed M, Alnahdi M, Aljubour Z, Alzahrani M (2023) Improved quality of life of patients with sickle cell disease after allogeneic stem cell transplant: another indication for transplant. Hematol Oncol Stem Cell Ther. ;17(1):37\u201342. https:\/\/doi.org\/10.56875\/2589-0646.1107. PMID: 37581462","DOI":"10.56875\/2589-0646.1107"},{"issue":"1","key":"6886_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3324\/haematol.2018.213207","volume":"105","author":"F Bernaudin","year":"2020","unstructured":"Bernaudin F, Dalle JH, Bories D, de Latour RP, Robin M, Bertrand Y, Pondarre C, Vannier JP, Neven B, Kuentz M, Maury S, Lutz P, Paillard C, Yakouben K, Thuret I, Galambrun C, Dhedin N, Jubert C, Rohrlich P, Bay JO, Suarez F, Raus N, Vernant JP, Gluckman E, Poirot C, Soci\u00e9 G (2020) Soci\u00e9t\u00e9 Fran\u00e7aise de greffe de Moelle et de Th\u00e9rapie Cellulaire. Long-term event-free survival, chimerism, and fertility outcomes in 234 patients with sickle-cell anemia younger than 30 years after myeloablative conditioning and matched-sibling transplantation in France. Haematologica 105(1):91\u2013101. https:\/\/doi.org\/10.3324\/haematol.2018.213207PMID: 31097628. PMCID: PMC6939536","journal-title":"Haematologica"},{"issue":"13","key":"6886_CR11","doi-asserted-by":"publisher","first-page":"4582","DOI":"10.1182\/blood-2003-03-0712","volume":"102","author":"LS Kean","year":"2003","unstructured":"Kean LS, Manci EA, Perry J, Balkan C, Coley S, Holtzclaw D, Adams AB, Larsen CP, Hsu LL, Archer DR (2003) Chimerism and cure: hematologic and pathologic correction of murine sickle cell disease. Blood 102(13):4582\u20134593","journal-title":"Blood"},{"issue":"Suppl 1","key":"6886_CR12","first-page":"A180","volume":"30","author":"\u00c1N Moraza","year":"2023","unstructured":"Moraza \u00c1N, Pe\u00f1a EGH, Fresneda MS, Fern\u00e1ndez-Llamazares CM, Rodr\u00edguez SM, Sender IT et al (2023) 4CPS-013 Treosulfan-based conditioning regimen for allogeneic hematopoietic stem cell transplantation in children with sickle cell disease: efficacy and safety. Eur J Hosp Pharm 30(Suppl 1):A180\u2013A180","journal-title":"Eur J Hosp Pharm"},{"issue":"1","key":"6886_CR13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.bbmt.2017.08.039","volume":"24","author":"AB Pawlowska","year":"2018","unstructured":"Pawlowska AB, Cheng JC, Karras NA, Sun W, Wang LD, Bell AD et al (2018) HLA haploidentical stem cell transplant with pretransplant immunosuppression for patients with sickle cell disease. Biol Blood Marrow Transpl 24(1):185\u2013189","journal-title":"Biol Blood Marrow Transpl"},{"issue":"6","key":"6886_CR14","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.bbmt.2018.11.027","volume":"25","author":"J de la Fuente","year":"2019","unstructured":"de la Fuente J, Dhedin N, Koyama T, Bernaudin F, Kuentz M, Karnik L et al (2019) Haploidentical bone marrow transplantation with Post-Transplantation cyclophosphamide plus Thiotepa improves donor engraftment in patients with sickle cell anemia : results of an international learning collaborative. Biol Blood Marrow Transpl 25(6):1197\u20131209","journal-title":"Biol Blood Marrow Transpl"},{"issue":"12","key":"6886_CR15","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.jtct.2021.09.009","volume":"27","author":"M Aydin","year":"2021","unstructured":"Aydin M, Dovern E, Leeflang MM, de la Fuente J, Kassim AA, Biemond BJ, Nur E (2021) Haploidentical allogeneic stem cell transplantation in sickle cell disease: a systematic review and meta-analysis. Transplantation Cell Therapy 27(12):1004\u2013e1","journal-title":"Transplantation Cell Therapy"},{"issue":"2","key":"6886_CR16","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41409-020-01054-3","volume":"56","author":"G Kharya","year":"2021","unstructured":"Kharya G, Bakane A, Agarwal S, Rauthan A (2021) Pre-transplant myeloid and immune suppression, upfront plerixafor mobilization and post-transplant cyclophosphamide: novel strategy for haploidentical transplant in sickle cell disease. Bone Marrow Transplant 56(2):492\u2013504","journal-title":"Bone Marrow Transplant"},{"key":"6886_CR17","doi-asserted-by":"publisher","first-page":"1330688","DOI":"10.3389\/fmed.2024.1330688","volume":"11","author":"HA BinAmir","year":"2024","unstructured":"BinAmir HA, AlAhmari A, AlQahtani A, Mohamed G, Alotaibi F, AlShamrani M, AlSaeed A, AlGhanmi S, Heji A, Alreshaid A, AlKawi A (2024) Posterior reversible encephalopathy syndrome post stem cell transplantation in sickle cell disease: case series and literature review. Front Med 11:1330688","journal-title":"Front Med"},{"key":"6886_CR18","unstructured":"Wright KYS Cell Specific Holistic Management Framework Design(Doctoral dissertation, Capella University)"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06886-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-06886-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06886-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:59:34Z","timestamp":1776405574000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-06886-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["6886"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-06886-5","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"202"}}